Finance

Lists
Why is PYXS up ၂.၀၁%?
Dive Deeper
PYXS:NASDAQ
Pyxis Oncology Inc
၂.၀၃ US$
+၂.၀၁%
(+၀.၀၄၀) 1D
၂.၀၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PYXS...
Open
၁.၉၉ US$
High
၂.၀၆ US$
Low
၁.၉၈ US$
Mkt. cap
၂၄.၁၇ ကုဋေ
Avg. vol.
၁.၂၅ သန်း
Volume
၉.၅၀ သိန်း
52-wk high
၅.၅၅ US$
52-wk low
၁.၀၃ US$
EPS
-၁.၄၀ US$
Beta
၁.၃၇
Shares outstanding
၁၁.၉၅ ကုဋေ
No. of employees
၅၆
Open
၁.၉၉ US$
High
၂.၀၆ US$
Low
၁.၉၈ US$
Mkt. cap
၂၄.၁၇ ကုဋေ
Avg. vol.
၁.၂၅ သန်း
Volume
၉.၅၀ သိန်း
52-wk high
၅.၅၅ US$
52-wk low
၁.၀၃ US$
EPS
-၁.၄၀ US$
Beta
၁.၃၇
Shares outstanding
၁၁.၉၅ ကုဋေ
No. of employees
၅၆
News stories
From web sources and news partners
Investing.com Nigeria
Investing.com Nigeria
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Form 4 Pyxis Oncology Inc For: 10 October By Investing.com
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
Warrants for 4.9 million shares are included in a passive stake in Pyxis Oncology (PYXS).
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁ ရက်
GordonMD Global Investments LP Adds 17,963,805 Shares of Pyxis O
About Pyxis Oncology Inc
CEO-
Employees၅၆
Founded၂၀၁၈
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to PYXS in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PYXS in the last 3 months.
Highest
Current ၂.၀၃ US$
၁၉.၀၀ US$ (+၈၃၅.၉၆%)
Average
၉.၀၀ US$ (+၃၄၃.၃၅%)
Lowest
၆.၀၀ US$ (+၁၉၅.၅၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
၆.၀၀ US$
+၁၉၅.၆%
10/08/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
၈.၀၀ US$
+၂၉၄.၁%
10/01/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
၈.၀၀ US$
+၂၉၄.၁%
09/26/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
09/09/2026
Alexandra Ramsey
William Blair
Hold
Reiterated
-
-
09/09/2026
Derek Archila
Wells Fargo
Buy
Reiterated
၁၉.၀၀ US$
+၈၃၆%
09/10/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
၇.၀၀ US$
+၂၄၄.၈%
08/17/2026
Robert Driscoll
Wedbush
Buy
Reiterated
၆.၀၀ US$
+၁၉၅.၆%
08/14/2026
Unknown Analyst
Guggenheim
Buy
Maintained
၇.၀၀ US$
+၂၄၄.၈%
06/29/2026
Last report
၂၀၂၆ ဩ ၁၃
Fiscal period
Q2 2026
-၀.၄၀ US$ / -၀.၃၅ US$
-၁၄.၂၉%miss
Revenue / Est. (USD)
- / ၂.၂၂ သောင်း
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
၁.၁၀ ကုဋေ
-
-
Cost of goods sold
-
၂.၃၉ သန်း
-
-
Cost of revenue
-
၂.၃၉ သန်း
-
-
Research and development expenses
၁.၇၈ ကုဋေ
၂.၁၇ ကုဋေ
၂.၀၀ ကုဋေ
၁.၆၁ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၉၇ သန်း
၄.၅၄ သန်း
၃.၇၅ သန်း
၉.၅၄ သန်း
Operating expense
၂.၂၈ ကုဋေ
၂.၆၃ ကုဋေ
၂.၃၇ ကုဋေ
၂.၅၆ ကုဋေ
Total operating expenses
၂.၂၈ ကုဋေ
၂.၈၆ ကုဋေ
၂.၃၇ ကုဋေ
၂.၅၆ ကုဋေ
Operating income
-၂.၂၈ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၃၇ ကုဋေ
-၂.၅၆ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၂.၂၀ ကုဋေ
-၁.၇၀ ကုဋေ
-၂.၃၃ ကုဋေ
-၂.၅၃ ကုဋေ
EBT excluding unusual items
-၂.၂၀ ကုဋေ
-၁.၇၀ ကုဋေ
-၂.၃၃ ကုဋေ
-၂.၅၃ ကုဋေ
Income tax expense
-
၁.၁၀ သန်း
-
-
Effective tax rate
-
-၆.၄၉%
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၂၀ ကုဋေ
-၁.၈၁ ကုဋေ
-၂.၃၃ ကုဋေ
-၂.၅၃ ကုဋေ
Net profit margin
-
-၁၆၄.၀၃%
-
-
Earnings per share
-၀.၃၅
-၀.၂၉
-၀.၃၇
-၀.၄၀
Interest and investment income
၇.၇၄ သိန်း
၆.၀၀ သိန်း
၄.၅၇ သိန်း
၂.၅၅ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၇.၇၄ သိန်း
၆.၀၀ သိန်း
၄.၅၇ သိန်း
၂.၅၅ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၂၂ ကုဋေ
-၁.၄၇ ကုဋေ
-၂.၃၃ ကုဋေ
-၂.၅၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ